BARDA DRIVe ImmuneChip+
Funds advanced immune and biological testing platforms for medical countermeasure development through challenge-style calls.
ImmuneChip+ funds advanced in vitro platforms and microphysiological systems incorporating immune components, targeting four goals: automated manufacturing and biosensor integration; modular multi-tissue platforms; CBRN threat injury/disease modeling; and biological/clinical data recapitulation. The program is DRIVe's dedicated early-technology BAA vehicle for organ-on-chip and organ chip-adjacent R&D.
BiotechMedtechSynthetic Biology
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.